Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up

Kaohsiung Journal of Medical Sciences

Volumn 27, Issue 7, 2011, Pages 251-257

  Liao, Yen Nung ^a   Liu, Ching Shen ^b   Tsai, Tong Rong ^c   Hung, Yu Chiang ^a   Chang, Shun Jen ^d   Lin, Hong Long ^e   Chen, Ying Chou ^a   Lai, Han Ming ^a   Yu, Shan Fu ^a   Chen, Chung Jen ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b Kaohsiung Municipal Chinese Medical Hospital   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anti dsDNA; Complementary and alternative medicine; Steroid; Systemic lupus erythematosus; Traditional Chinese medicine

Indexed keywords

CHINESE DRUG; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DAN CHI LIU WEI; STEROID; UNCLASSIFIED DRUG;

ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG FEVER; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC LUPUS ERYTHEMATOSUS; UPPER RESPIRATORY TRACT INFECTION; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ADULT; ANTIBODIES, ANTINUCLEAR; BLOOD SEDIMENTATION; CHINA; COMPLEMENT C3; COMPLEMENT C4; DOUBLE-BLIND METHOD; DRUG DOSAGE CALCULATIONS; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHYTOTHERAPY; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; STEROIDS; TREATMENT OUTCOME;

EID: 79960370826     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.kjms.2011.03.001     Document Type: Article

References (24)

1. M.B. Urowitz, M. Feletar, I.N. Bruce, D. Ibañez, and D.D. Gladman Prolonged remission in systemic lupus erythematosus J Rheumatol 32 2005 1467 1472 (Pubitemid 41113966)
2. R.M. Santaella, and F.W. Fraunfelder Ocular adverse effects associated with systemic medications: recognition and management Drugs 67 2007 75 93 (Pubitemid 46115915)
3. E. Casado, J. Gratacós, C. Tolosa, J.M. Martínez, I. Ojanguren, and A. Ariza Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patients Ann Rheum Dis 65 2006 385 390 (Pubitemid 43268230)
4. W.R. Connell, M.A. Kamm, J.K. Ritchie, and J.E. Lennard-Jones Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience Gut 34 1993 1081 1085 (Pubitemid 23245359)
5. O.A. Shaye, M. Yadegari, M.T. Abreu, F. Poordad, K. Simon, and P. Martin Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD Patients Am J Gastroenterol 102 2007 2488 2494 (Pubitemid 47631795)
6. S. Caillard, V. Dharnidharka, L. Agodoa, E. Bohen, and K. Abbott Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression Transplantation 80 2005 1233 1243 (Pubitemid 41746802)
7. G.J. Jakab, and G.A. Warr Lung defenses against viral and bacterial challenges during immunosuppression with cyclophosphamide in mice Am Rev Respir Dis 123 1981 524 528 (Pubitemid 11098391)
8. L.B. Kenney, M.R. Laufer, F.D. Grant, H. Grier, and L. Diller High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood Cancer 91 2001 613 621 (Pubitemid 32105709)
9. W.V. Fairchild, C.R. Spence, H.D. Solomon, and M.P. Gangai The incidence of bladder cancer after cyclophosphamide therapy J Urol 122 1979 163 164 (Pubitemid 9248283)
10. A.D. Moore, M.A. Petri, S. Manzi, D.A. Isenberg, C. Gordon, and J.L. Senécal The use of alternative medical therapies in patients with systemic lupus erythematosus Trination Study Group. Arthritis Rheum 43 2000 1410 1418 (Pubitemid 30416329)
11. K.P. Leong, L.Y. Pong, and S.P. Chan Why lupus patient use alternative medicine Lupus 12 2003 659 664 (Pubitemid 37173661)
12. J.J. Shen, C.J. Lin, J.L. Huang, K.H. Hsieh, and M.L. Kuo The effect of liu-wei-di-huang wan on cytokine gene expression from human peripheral blood lymphocytes Am J Chin Med 31 2003 247 257
13. Y.J. Wei, S.L. Li, and P. Li Simultaneous determination of seven active components of Fufang Danshen tablet by high performance liquid chromatography Biomed Chromatogr 21 2007 1 9 (Pubitemid 46164985)
14. th ed. Pharmacopoeia of Peoples Republic of China Vol. I 2005 National Commission of Chinese Pharmacopoeia Beijing p. 527-28 [in Chinese]
15. Y.J. Wei, L.W. Qi, P. Li, H.W. Luo, L. Yi, and L.H. Sheng Improved quality control method for Fufang Danshen preparations through simultaneous determination of phenolic acids, saponins and diterpenoid quinones by HPLC coupled with diode array and evaporative light scattering detectors J Pharm Biomed Anal 45 2007 775 784 (Pubitemid 350087554)
16. L. Liu, and L. Lu Pharmacology study and clinical application of Fufang Danshen tablet HeiLongJiang Med J 18 2005 59 [in Chinese]
17. J.L. Yang Observation of Fufang Danshen Diwan on hemorheological and blood lipid parameters in microvascular complications of diabetes World J of Integr Tradit West Med 12 2007 598 599 [in Chinese]
18. X.Y. Chen, S.X. Li, and J. Guan Clinical investigation on compound Danshen dropping pill in treatment of coronary heart disease angina pectoris J Med Theor Pract 19 2006 377 379 [in Chinese]
19. S. Manzi, E.N. Meilahn, J.E. Rairie, C.G. Conte, T.A. Medsger Jr., and L. Jansen-McWilliams Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study Am J Epidemiol 145 1997 408 415 (Pubitemid 27084212)
20. M.C. Hochberg Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1997 1725
21. C. Bombardier, D.D. Gladman, M.B. Urowitz, D. Caron, C.H. Chang The Committee on Prognosis Studies in SLE The development and validation of the SLE disease activity index (SLEDAI) Arthritis Rheum 19 1992 608 611
22. D.D. Gladman, M.B. Urowitz, A. Kagal, and D. Hallett Accurately describing changes in disease activity in Systemic Lupus Erythematosus J Rheumatol 27 2000 377 379 (Pubitemid 30095467)
23. F.D. Debelle, J.L. Vanherweghem, and J.L. Nortier Aristolochic acid nephropathy: a worldwide problem Kidney Int 74 2008 158 169 (Pubitemid 351915079)
24. Y. Lian, P. Zhen, X.H. Guan, Q. Hu, L.H. Lei, and L. Tao Research on the intervention of Liuwei DiHuang pill (LDP) on therapeutic effectiveness and adverse reaction of hormonotherapy and immunosuppressive agent in treating systemic Lupus erythematosus (SLE) J Sichuan Tradit Chin Med 24 2006 20 21 [in Chinese]